BASOSQUAMOUS CARCINOMA OF SKIN

This adverse event was reported 58 times

These drugs are most commonly taken by patients reporting BASOSQUAMOUS CARCINOMA OF SKIN:

# Drug Count
0 ADALIMUMAB 12
1 LENALIDOMIDE 12
2 OMEPRAZOLE MAGNESIUM 6
3 ASPIRIN 4
4 ASPIRIN 325 MG 4
5 ASPIRIN 81 MG 4
6 DEXAMETHASONE 4
7 DEXAMETHASONE 1.5 MG 4
8 IBRUTINIB 4
9 ACETAMINOPHEN 3
See all common drugs associated with BASOSQUAMOUS CARCINOMA OF SKIN

BASOSQUAMOUS CARCINOMA OF SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMIQUIMOD 2 0.0009
1 PSYLLIUM HUSK 1 0.0007
2 FLUVOXAMINE MALEATE 1 0.0004
3 LIDOCAINE HCL 1 0.0004
4 BARICITINIB 1 0.0003
5 CHLORAMBUCIL 1 0.0003
6 DOCUSATE CALCIUM 1 0.0002
7 FLECAINIDE ACETATE 1 0.0002
8 CLADRIBINE 1 0.0001
9 CLOBETASOL PROPIONATE OINTMENT USP, 0.05% 1 0.0001
See all drugs enriched for association with BASOSQUAMOUS CARCINOMA OF SKIN

BASOSQUAMOUS CARCINOMA OF SKIN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 2 0.0001
1 Anticholinergic [EPC] 1 0.0001
2 Antimetabolite Immunosuppressant [EPC] 1 0.0000
3 Alkaloid [EPC] 1 0.0000
4 Iron Chelator [EPC] 1 0.0000
5 Phenothiazine [EPC] 1 0.0000
6 Interleukin-17A Antagonist [EPC] 1 0.0000
7 Parathyroid Hormone Analog [EPC] 3 0.0000
8 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
9 Thalidomide Analog [EPC] 12 0.0000
See all drug classes enriched for association with BASOSQUAMOUS CARCINOMA OF SKIN